2020 AliquantumRx receives TEDCO funding AliquantumRx Inc. announces a phase III MII funding for a project entitled “Development of Cethromycin Read More » July 27, 2020
2019 New Patent “Salts and Polymorphs of Cethromycin for the Treatment of Disease” AliquantumRx Inc. announces the filing of a provisional patent application No. 62/942,508 entitled “Salts and Read More » December 2, 2019
2019 AliquantumRx Inc. Raises $500,000 from Angel Investors AliquantumRx Inc. announces that it has attracted an initial capital investment of up to $500,000 Read More » January 25, 2019